BlackRock’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$193K Sell
85,570
-6,754
-7% -$15.2K ﹤0.01% 4605
2025
Q1
$198K Sell
92,324
-1,381
-1% -$2.96K ﹤0.01% 4557
2024
Q4
$227K Buy
93,705
+1,696
+2% +$4.1K ﹤0.01% 4542
2024
Q3
$225K Buy
92,009
+2,303
+3% +$5.62K ﹤0.01% 4455
2024
Q2
$231K Buy
89,706
+411
+0.5% +$1.06K ﹤0.01% 4469
2024
Q1
$261K Buy
89,295
+1,537
+2% +$4.49K ﹤0.01% 4472
2023
Q4
$203K Sell
87,758
-1,040
-1% -$2.4K ﹤0.01% 4557
2023
Q3
$232K Sell
88,798
-9,232
-9% -$24.1K ﹤0.01% 4570
2023
Q2
$351K Buy
98,030
+8,359
+9% +$29.9K ﹤0.01% 4503
2023
Q1
$195K Sell
89,671
-16,229
-15% -$35.4K ﹤0.01% 4699
2022
Q4
$1.27M Buy
105,900
+3,701
+4% +$44.5K ﹤0.01% 4251
2022
Q3
$662K Sell
102,199
-36,853
-27% -$239K ﹤0.01% 4544
2022
Q2
$637K Sell
139,052
-1,691,114
-92% -$7.75M ﹤0.01% 4603
2022
Q1
$15.8M Buy
1,830,166
+271,559
+17% +$2.35M ﹤0.01% 3247
2021
Q4
$22.3M Buy
1,558,607
+125,059
+9% +$1.79M ﹤0.01% 3151
2021
Q3
$31.5M Buy
1,433,548
+164,018
+13% +$3.6M ﹤0.01% 2929
2021
Q2
$17M Buy
1,269,530
+1,190,970
+1,516% +$15.9M ﹤0.01% 3341
2021
Q1
$798K Buy
78,560
+9,825
+14% +$99.8K ﹤0.01% 4479
2020
Q4
$292K Sell
68,735
-20,266
-23% -$86.1K ﹤0.01% 4342
2020
Q3
$232K Buy
89,001
+16,963
+24% +$44.2K ﹤0.01% 4282
2020
Q2
$254K Buy
72,038
+26,042
+57% +$91.8K ﹤0.01% 4241
2020
Q1
$140K Sell
45,996
-11,840
-20% -$36K ﹤0.01% 4217
2019
Q4
$298K Sell
57,836
-13,793
-19% -$71.1K ﹤0.01% 4199
2019
Q3
$228K Sell
71,629
-2,662
-4% -$8.47K ﹤0.01% 4260
2019
Q2
$267K Buy
74,291
+2,423
+3% +$8.71K ﹤0.01% 4264
2019
Q1
$261K Buy
71,868
+2,525
+4% +$9.17K ﹤0.01% 4157
2018
Q4
$208K Buy
69,343
+40,114
+137% +$120K ﹤0.01% 4175
2018
Q3
$142K Buy
29,229
+1,188
+4% +$5.77K ﹤0.01% 4327
2018
Q2
$209K Buy
+28,041
New +$209K ﹤0.01% 4239